IAU Open Access

MIDKINE CAN BE EVALUATED AS A NEW OVARIAN RESERVE MARKER AT POLYCYSTIC OVARY SYNDROME CASES EXCEPT FOR UNEXPLAINED INFERTILITY CASES.

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account